G.L. Pharma GmbH Laboratorios Liconsa S.A.
PolandAll drugs from this manufacturer
-
The medicine is used in the treatment of severe, chronic pain in adults and in children and adolescents over 6 years of age, which cannot be controlled by other analgesic (opioid) medicines.
Dosage form: tablets, prolonged release
Active substance Dosage tapentadol tartrate 41.9525 mg ATC: N02AX06
-
The medicine is used to treat severe, chronic pain in adults and in children and adolescents over 6 years of age, which cannot be controlled with other opioid analgesics.
Dosage form: tablets, prolonged release
Active substance Dosage tapentadol tartrate 83.905 mg ATC: N02AX06
-
The medicine is used to treat severe, chronic pain in adults and in children and adolescents over 6 years of age, which cannot be managed with other opioid analgesics.
Dosage form: tablets, prolonged release
Active substance Dosage tapentadol tartrate 167.81 mg ATC: N02AX06
-
The medicine is used to treat severe, chronic pain in adults and in children and adolescents over 6 years of age, which cannot be managed with other analgesic (opioid) medicines.
Dosage form: tablets, prolonged release
Active substance Dosage tapentadol tartrate 251.715 mg ATC: N02AX06
-
The medicine is used to treat severe, chronic pain in adults and in children and adolescents over 6 years of age, which cannot be controlled with other painkillers (opioids).
Dosage form: tablets, prolonged release
Active substance Dosage tapentadol tartrate 335.62 mg ATC: N02AX06
-
The medicine is used to treat severe, chronic pain in adults and in children and adolescents over 6 years of age, which cannot be managed with other painkillers (opioids).
Dosage form: tablets, prolonged release
Active substance Dosage tapentadol tartrate 419.525 mg ATC: N02AX06